Scientific Program 2021

Session 1 - Keynotes and Updates

15:30 - 15:35

Session 1 - Keynotes and Updates
Toh Han Chong
Shaheenah Dawood

15:35 - 15:55

Session 1 - GI Malignancies: A year in review
Shaheenah Dawood

15:55 - 16:30

Symposium By MSD - Practical integration of Immunotherapy in Upper GI Malignancies
Dora Lai-Wan Kwong
Choo Su Pin

16:30 - 16:50

Symposium by DKSH : How do we manage advanced Gastric Cancer in 2021: Focus on treatment sequencing and case studies
Raghav Sundar

16:50 - 17:20

GI Molecular Tumor Board
Raghav Sundar
Matthew NG
Yong Wei Peng
Kim Guo Wei
Rachel Wong
SESSION 2: Esophageal and Gastric Cancers
Chairperson:
Jimmy So
Matthew NG

17:20 - 17:40

Evolving role of adjuvant immune check point inhibitors in upper GI Malignancies
Jimmy So
Matthew NG
Ronan Kelly

17:40 - 18:15

Symposium by AstraZeneca - Management of HER2+ metastatic Gastric Cancer: New Decade New Approach
Chee Cheng Ean
Choo Su Pin

18:15 - 18:55

Symposium by BMS : Immunotherapy in Gastroesophageal Cancers
Elizabeth Smyth

18:55 - 19:00

Q&A
SESSION 3: Hepatobiliary Malignancies
Chairperson:
Pierce Chow

19:00 - 19:30

Debate: This house believes that combination systemic therapy in HCC will make single agent systemic therapy much less relevant
Lorenza Rimassaa
Thomas Yau
Toh Han Chong

19:30 - 20:00

Symposium by IPSEN - Systemic therapy in advanced HCC – from today’s practice to tomorrow’s options
Arndt Vogel

20:00 - 20:15

What’s new in the treatment of Biliary Tract Cancer in 2021?
Muhammad Azrif
Changhoon Yoo

20:15 - 20:30

Biliary Tract Cancer : Round Table Discussion
Muhammad Azrif
Ghassan Abou-Alfa
Changhoon Yoo
Toh Han Chong

20:30 - 21:00

Symposium By Roche - Molecular Tumor Board - Evolving treatments for BCLC-B and BCLC-C Child Pugh-B HCC
Stephen L. Chan
David Ng
Rheun-Chuan Lee
Peter Galle
Toh Han Chong
Pierce Chow
APGCS 2021 : DAY 2 - 15th August

16:00 - 16:05

Welcome Back & Introductions
Shailesh Shrikhande
Pierce Chow

16:05 - 16:35

Symposium by Natera - Detecting Molecular Residual Disease in Colorectal Rectal Cancers using ctDNA
Alexey Aleshin

16:35 - 16:55

Session 4: Is neoadjuvant therapy the standard of care in resectable Pancreatic Cancer?
Bhawna Sirohi

16:55 - 17:15

Session 4: Novel targets in the management of Metastatic Pancreatic Cancer: What does the future hold?
Eileen O'Reilly

17:15 - 17:45

Session 4: Molecular Tumor Board - Adjuvant and neoadjuvant treatment options in resectable and borderline resectable pancreatic cancer, Treatment approaches in locally advanced unresectable pancreatic cancer, management of metastatic cancer
Shailesh Shrikhande
Bhawna Sirohi
Eileen O'Reilly
Ho Gwo Fuang
Pierce Chow

17:45 - 18:05

Symposium by Guardant: When & How to use Liquid Biopsies in early stage & metastatic Colorectal Cancer
Tobias Arkenau

18:05 - 18:25

How to use comprehensive molecular & immune profiling in colorectal cancer patients : 2021 & beyond
Chee Cheng Ean
Iain Tan

18:25 - 18:45

Session 5: What is the optimal treatment protocol in different subsets of rectal cancer
Connie Yip

18:45 - 19:05

Session 5: Current & “under-investigation” roles of immune checkpoint inhibitors in MSI-H & MSS metastatic CRC
Kai-Keen Shiu

19:05 - 19:30

Session 5: Colorectal Tumor Board: Patients with interesting molecular profiles
Kai-Keen Shiu
Chee Cheng Ean
Choo Su Pin
Tobias Arkenau
Connie Yip
Iain Tan